| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
138,140,000 |
| Market
Cap: |
142.28(M) |
| Last
Volume: |
3,241,097 |
Avg
Vol: |
3,311,042 |
| 52
Week Range: |
$0.937 - $1.31 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 807 |
| Guru Rank Value : 1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Spectrum Pharmaceuticals is a biopharmaceutical company. Co. is engaged in acquiring, developing, and commercializing targeted oncology therapies. Co. has two drugs in late-stage development: Eflapegrastim, which is a long-acting granulocyte colony-stimulating factor for the treatment of chemotherapy-induced neutropenia; as well as Poziotinib, which is an irreversible tyrosine kinase inhibitor under investigation for non-small cell lung cancer tumors with various mutations.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
50,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$22,500 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
32,387 |
490,738 |
| Total Sell Value |
$0 |
$0 |
$35,496 |
$343,474 |
| Total People Sold |
0 |
0 |
1 |
7 |
| Total Sell Transactions |
0 |
0 |
1 |
19 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Krassner Stuart Mitchell |
Director |
– • – |
2015-12-01 |
4 |
D |
$6.00 |
$70,428 |
D/D |
(11,738) |
41,250 |
|
- |
|
| Krassner Stuart Mitchell |
Director |
– • – |
2015-12-01 |
4 |
OE |
$4.26 |
$63,900 |
D/D |
15,000 |
52,988 |
|
- |
|
| Turgeon Joseph W. |
President & COO |
• – – |
2015-10-29 |
4 |
D |
$5.32 |
$9,097 |
D/D |
(1,710) |
217,747 |
|
- |
|
| Vyas Dolatrai |
Director |
– • – |
2015-07-07 |
4 |
D |
$6.96 |
$5,512 |
D/D |
(792) |
25,003 |
|
- |
|
| Lenaz Luigi Md |
Director |
– • – |
2015-07-07 |
4 |
D |
$6.96 |
$4,350 |
D/D |
(625) |
55,327 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2015-07-07 |
4 |
D |
$6.96 |
$6,132 |
D/D |
(881) |
25,456 |
|
- |
|
| Krassner Stuart Mitchell |
Director |
– • – |
2015-07-07 |
4 |
D |
$6.96 |
$4,350 |
D/D |
(625) |
37,988 |
|
- |
|
| Cohen Raymond W |
Director |
– • – |
2015-07-07 |
4 |
D |
$6.96 |
$4,350 |
D/D |
(625) |
29,375 |
|
- |
|
| Maida Anthony E III |
Director |
– • – |
2015-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
26,337 |
|
- |
|
| Lenaz Luigi Md |
Director |
– • – |
2015-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
55,952 |
|
- |
|
| Gagnon Gilles |
Director |
– • – |
2015-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
65,000 |
|
- |
|
| Vyas Dolatrai |
Director |
– • – |
2015-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
25,795 |
|
- |
|
| Cohen Raymond W |
Director |
– • – |
2015-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
30,000 |
|
- |
|
| Krassner Stuart Mitchell |
Director |
– • – |
2015-06-29 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
38,613 |
|
- |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2015-06-03 |
4 |
D |
$6.19 |
$62,315 |
D/D |
(10,067) |
121,699 |
|
- |
|
| Allen Lee F Md Phd |
Chief Medical Officer |
• – – |
2015-05-08 |
4 |
D |
$5.89 |
$11,974 |
D/D |
(2,033) |
80,381 |
|
- |
|
| Turgeon Joseph W. |
President & COO |
• – – |
2015-04-17 |
4 |
D |
$6.09 |
$49,968 |
D/D |
(8,205) |
219,457 |
|
- |
|
| Allen Lee F Md Phd |
Chief Medical Officer |
• – – |
2015-03-25 |
4 |
D |
$6.13 |
$4,984 |
D/D |
(813) |
82,414 |
|
- |
|
| Allen Lee F Md Phd |
Chief Medical Officer |
• – – |
2015-03-18 |
4 |
D |
$6.38 |
$19,453 |
D/D |
(3,049) |
83,227 |
|
- |
|
| Turgeon Joseph W. |
President & COO |
• – – |
2015-02-18 |
4 |
D |
$7.23 |
$26,462 |
D/D |
(3,660) |
227,662 |
|
- |
|
| Turgeon Joseph W. |
President & COO |
• – – |
2015-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
231,322 |
|
- |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2015-02-18 |
4 |
D |
$7.23 |
$20,765 |
D/D |
(2,872) |
131,766 |
|
- |
|
| Gustafson Kurt A |
EVP & Chief Financial Officer |
• – – |
2015-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
134,638 |
|
- |
|
| Allen Lee F Md Phd |
Chief Medical Officer |
• – – |
2015-02-18 |
4 |
D |
$7.23 |
$12,465 |
D/D |
(1,724) |
86,276 |
|
- |
|
| Allen Lee F Md Phd |
Chief Medical Officer |
• – – |
2015-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
88,000 |
|
- |
|
658 Records found
|
|
Page 17 of 27 |
|
|
